Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
KNSA holding history
Kiniksa Pharmaceuticals International, plc in every 13F filed by Fairmount Funds Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNSA overviewAll 13F holders of KNSAFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,319,688−100.0% | Sold out | Holders |
| Q4 2025 | 1,319,688 | $54.4M | 4.1% | −453,151−25.6% | Reduced | Holders |
| Q3 2025 | 1,772,839 | $68.8M | 6.2% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,772,839 | $49.1M | 6.4% | +670,591+60.8% | Added | Holders |
| Q1 2025 | 1,102,248 | $24.5M | 3.8% | −1,092,093−49.8% | Reduced | Holders |
| Q4 2024 | 2,194,341 | $43.4M | 4.3% | −1,010,500−31.5% | Reduced | Holders |
| Q3 2024 | 3,204,841 | $80.1M | 6.5% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,204,841 | $59.8M | 6.8% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,204,841 | $63.2M | 6.9% | +321,620+11.2% | Added | Holders |
| Q4 2023 | 2,883,221 | $50.6M | 5.3% | +408,660+16.5% | Added | Holders |
| Q3 2023 | 2,474,561 | $43.0M | 5.2% | +1,770,102+251.3% | Added | Holders |
| Q2 2023 | 704,459 | $9.92M | 1.4% | +704,459 | New | Holders |